- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01479725
Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis
January 12, 2017 updated by: Kenneth Peters, MD
A Prospective Trial Comparing the Response to Hyperbaric Oxygen Treatment in Patients With Ulcerative and Non-Ulcerative Interstitial Cystitis
To review the results of Hyperbaric Oxygen therapy (HBOT) on the symptoms of interstitial cystitis (IC).
To determine if there is greater symptom improvement in the ulcerative vs the non-ulcerative patients with interstitial cystitis.
Study Overview
Detailed Description
There are multiple published studies outside of the United States on HBOT for treatment of interstitial cystitis.
None of these studies compares ulcerative IC and non-ulcerative IC.
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Royal Oak, Michigan, United States, 48073
- Beaumont Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Interstitial cystitis.
- Urinary frequency of at least 8 times per 24 hours period.
- Patients with ulcerative IC must have undergone previous biopsy negative for cancer.
- Patients must agree to not begin any additional treatment for IC until study completion.
Exclusion Criteria:
- Absolute or relative contraindication to hyperbaric oxygen treatment.
- Patients dependent on intermittent catheterization or indwelling catheter to empty bladder.
- Any imminent change in residence, which could compromise compliance.
- Unlikely to be compliant due to unmanaged medical or psychological problems.
- Severe debilitating concurrent medical conditions.
- A history of pelvic radiation, bladder stone, bladder cancer or cancer in situ, or urethral cancer.
- Precious bladder or neurologic surgery which has affected bladder function.
- Currently has an active urethral stone, ureteral stone or urethral diverticulum.
- Subject misses more than 10 treatments.
- Severe claustrophobia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Ulcerative IC
HBOT for ulcerative IC
|
HBOT
Other Names:
|
EXPERIMENTAL: Non-Ulcerative IC
HBOT for non-ulcerative IC
|
HBOT
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global Response Assessment (GRA)
Time Frame: 3 months post treatment
|
The GRA measures overall improvement with therapy.
The patient's response describes their current condition compared to before they received hyperbaric oxygen therapy (HBOT).
Responses are: 1 Markedly Worse, 2 Moderately Worse, 3 Mildly Worse, 4 Unchanged, 5 Mildly Better, 6 Moderately Better and 7 Markedly Better.
|
3 months post treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kenneth Peters, MD, Beaumont Hospital, Royal Oak
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (ACTUAL)
August 1, 2012
Study Completion (ACTUAL)
May 1, 2013
Study Registration Dates
First Submitted
November 22, 2011
First Submitted That Met QC Criteria
November 23, 2011
First Posted (ESTIMATE)
November 24, 2011
Study Record Updates
Last Update Posted (ACTUAL)
March 3, 2017
Last Update Submitted That Met QC Criteria
January 12, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-247
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Interstitial Cystitis
-
Asan Medical CenterCompletedChronic Interstitial CystitisKorea, Republic of
-
St. Louis UniversityTerminated
-
St. Louis UniversityCompletedInterstitial Cystitis
-
Northwell HealthWithdrawnInterstitial CystitisUnited States
-
CAMC Health SystemCompletedInterstitial CystitisUnited States
-
UroGen Pharma Ltd.CompletedInterstitial Cystitis | ICIsrael
-
St. Louis UniversityCompleted
-
Drexel University College of MedicineMedtronicCompleted
-
AllerganTARIS Biomedical, Inc.TerminatedInterstitial CystitisUnited States, Canada
Clinical Trials on HBOT
-
Assaf Harofeh MCUnknown
-
RWTH Aachen UniversityCompletedWound Healing | MicrocirculationGermany
-
Assaf-Harofeh Medical CenterUnknownIntracranial Meningioma | Neurologic DeficitsIsrael
-
Assaf-Harofeh Medical CenterCompletedFibromyalgia | Chronic Pain SyndromeIsrael
-
Abington Memorial HospitalPhiladelphia College of Osteopathic MedicineCompletedStroke | Ischemic Stroke | Chronic Stroke | Motor DysfunctionUnited States
-
Assaf-Harofeh Medical CenterWeizmann Institute of Science; Office of Naval Research (ONR)RecruitingPTSD | Peritraumatic AmnesiaIsrael
-
Mrs. Thelma Zoegas FoundationLund University; Region Skåne Sweden; Gorthons Foundation Helsingborg SwedenCompletedDiabetes | Foot Ulcer | HealingSweden
-
Assaf-Harofeh Medical CenterCompletedErectile Dysfunction | Hyperbaric Oxygen TherapyIsrael